These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mesoporous silica nanoparticles in drug delivery and biomedical applications. Wang Y, Zhao Q, Han N, Bai L, Li J, Liu J, Che E, Hu L, Zhang Q, Jiang T, Wang S. Nanomedicine; 2015 Feb; 11(2):313-27. PubMed ID: 25461284 [Abstract] [Full Text] [Related]
3. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Tang F, Li L, Chen D. Adv Mater; 2012 Mar 22; 24(12):1504-34. PubMed ID: 22378538 [Abstract] [Full Text] [Related]
4. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles. Chen Y, Chen H, Shi J. Adv Mater; 2013 Jun 18; 25(23):3144-76. PubMed ID: 23681931 [Abstract] [Full Text] [Related]
5. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS. Small; 2010 Sep 20; 6(18):1952-67. PubMed ID: 20690133 [Abstract] [Full Text] [Related]
8. Mesoporous silica nanoparticles for tissue-engineering applications. Chen L, Zhou X, He C. Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov 20; 11(6):e1573. PubMed ID: 31294533 [Abstract] [Full Text] [Related]
9. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties. Zhu Y, Wang B, Chen J, He J, Qiu X. Curr Drug Deliv; 2023 Nov 20; 20(9):1337-1350. PubMed ID: 35713141 [Abstract] [Full Text] [Related]
10. Biocompatibility of mesoporous silica nanoparticles. Asefa T, Tao Z. Chem Res Toxicol; 2012 Nov 19; 25(11):2265-84. PubMed ID: 22823891 [Abstract] [Full Text] [Related]
12. Mesoporous Silica Nanoparticles-Based Nanoplatforms: Basic Construction, Current State, and Emerging Applications in Anticancer Therapeutics. Feng Y, Liao Z, Li M, Zhang H, Li T, Qin X, Li S, Wu C, You F, Liao X, Cai L, Yang H, Liu Y. Adv Healthc Mater; 2023 Jun 19; 12(16):e2201884. PubMed ID: 36529877 [Abstract] [Full Text] [Related]
17. Biosafety of mesoporous silica nanoparticles; towards clinical translation. Lérida-Viso A, Estepa-Fernández A, García-Fernández A, Martí-Centelles V, Martínez-Máñez R. Adv Drug Deliv Rev; 2023 Oct 19; 201():115049. PubMed ID: 37573951 [Abstract] [Full Text] [Related]
19. A systemic review on development of mesoporous nanoparticles as a vehicle for transdermal drug delivery. Kolimi P, Narala S, Youssef AAA, Nyavanandi D, Dudhipala N. Nanotheranostics; 2023 Oct 19; 7(1):70-89. PubMed ID: 36593800 [Abstract] [Full Text] [Related]
20. Functionalized mesoporous silica nanoparticles and biomedical applications. Hoang Thi TT, Cao VD, Nguyen TNQ, Hoang DT, Ngo VC, Nguyen DH. Mater Sci Eng C Mater Biol Appl; 2019 Jun 19; 99():631-656. PubMed ID: 30889738 [Abstract] [Full Text] [Related] Page: [Next] [New Search]